← All organizations

University of Rhode Island

Academic/HospitalWebsite ↗

Also known as: University of Rhode Island

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 1, 2024

Timeline

1890s

Jan 1, 1892
University of Rhode Island— Founded

Drugs by trial phase (11 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

lisdexamfetamine

Phase 3 (3 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

treprostinil

Phase 1 (2 own, 0 via acquisition)

Other trials (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06579209Lead sponsorN/ASep 1, 2024
NCT06223854CollaboratorN/AApr 25, 2024
NCT04139213CollaboratorPhase 2/Phase 3Jul 25, 2019
NCT04005469CollaboratorPhase 1/Phase 2Jul 1, 2019
NCT03752294Lead sponsorPhase 1Nov 30, 2018
NCT03766893CollaboratorEarly Phase 1Sep 1, 2017
NCT03063372CollaboratorN/AFeb 28, 2017
NCT02613585CollaboratorN/AFeb 29, 2016
NCT02039349CollaboratorPhase 1Jan 3, 2014
NCT01342445Reponsible party - principal investigatorPhase 4Sep 1, 2009
NCT01342445Lead sponsorPhase 4Sep 1, 2009
NCT01342445Overall official - principal investigatorPhase 4Sep 1, 2009

Details

Founded: Kingston, RI, US Jan 1, 1892
Last known activity: Sep 1, 2024